Bourneville-Pringle disease or tuberous sclerosis is a multisystem, genetically determined disease that manifests mainly in childhood and is manifested by the formation of benign neoplasms (hamartomas) in various organs and tissues. Tuberous sclerosis is a rare (orphan) disease. The prevalence of tuberous sclerosis among newborns ranges from 1:6000 to 1:10000. Tuberous sclerosis is inherited in an autosomal dominant manner. An analysis of a clinical case of a newborn child with tuberous sclerosis (Bourneville-Pringle disease) is presented. The peculiarity of the presented observation is the diagnosis of the disease during prenatal ultrasound screening in the third trimester with the identification of multiple space-occupying formations in the brain and heart of the fetus. Confirmation of the diagnosis in the early neonatal period is based on the presence of primary (major) diagnostic criteria: multiple cardiac rhabdomyomas, brain tubera and retinal hamartomas. The diagnosis was made primarily on the basis of data from echographic research methods, which have demonstrated their effectiveness in identifying typical signs of this disease in the perinatal period. Neonatologists should be wary of children with cardiac radbomyomas detected prenatally, due to the fact that this cardiac tumor is highly likely to be combined with tuberous sclerosis and is its diagnostic marker. In addition to heart damage, the early onset of the disease in the perinatal and postnatal periods manifests itself in damage to the central nervous system. Patients with tuberous sclerosis require lifelong monitoring from the first days of life by a multidisciplinary team of specialists with special attention to life-threatening complications (progressive hydrocephalus, status epilepticus, renal failure, respiratory failure). Managing a patient with this pathology is a complex multidisciplinary problem.